FARMINGDALE, N.Y., Nov. 11 /PRNewswire-FirstCall/ --Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today announced plans to release first quarter fiscal year 2009 financial results on Thursday afternoon, November 13, 2008. Michael A. McManus, President and Chief Executive Officer and Richard Zaremba, Senior VP and Chief Financial Officer, will host a conference call at 4:30 p.m. Eastern on Thursday, November 13, 2008 to discuss the Company's first quarter fiscal 2009 financial results.
Shareholders and other interested parties may participate in the conference call by dialing (866) 788-0543 (domestic) or (857) 350-1681 (international) and entering access code 21386797, a few minutes before the start of the call. A simultaneous webcast will be available via Misonix's website at http://www.misonix.com. The call will be archived on the Company's website for at least 90 days.
A recording of the live-call will be available approximately 2 hours after the event through November 20, 2008. The dial-in number to listen to the recording is (888) 286 8010 or (617) 801 6888. The replay access code is 80767628.
Misonix, Inc. (NASDAQ: MSON) designs, develops, manufactures and
markets therapeutic ultrasonic medical devices and laboratory equipment.
Misonix's therapeutic ultrasonic platform is the basis for several
innovative medical technologies. Addressing a combined market estimated to
be in excess of $3 billion annually; Misonix's proprietary ultrasonic
medical devices are used for wound debridement, cosmetic surgery,
neurosurgery, laparoscopic surgery, and other surgical and medical
applications. Additional information is available on the Company's Web site
Misonix Contact: Investor Relations Contact:
Richard Zaremba Kevin M. McGrath
Chief Financial Officer Cameron Associates, Inc.
631-694-9555 212 245 4577
|SOURCE Misonix, Inc.|
Copyright©2008 PR Newswire.
All rights reserved